Market Overview

AI-Driven Cardiac Ultrasound Company Bay Labs Announces Two Presentations at TCT2017


, a medical technology company at the forefront of applying
artificial intelligence to cardiovascular imaging, today announced that
Emeritus Professor of Medicine (Cardiology) at Emory University School
of Medicine and the company's Chief Medical Officer Randolph P. Martin,
M.D. FACC, FASE, has been invited to be a faculty member and present at
the upcoming 29th Transcatheter Cardiovascular Therapeutics (TCT) annual
scientific symposium of the Cardiovascular Research Foundation (CRF)
meeting in Denver. Dr. Martin's two presentations will focus on how
advances in artificial intelligence, machine learning, and deep learning
can impact the role that cardiovascular imaging and echocardiography
play in the diagnosis and management of heart diseases, especially those
affecting the heart valves.

Attendees will have the opportunity to learn more about artificial
intelligence and deep learning's role in echocardiography and valvular
heart diseases at the following presentations being made by Dr. Martin:

  • Using Artificial Intelligence (Machine Learning) to Direct
    Acquisition and Interpretation of Echocardiograms – Improving Access
    and Quality of Valve Disease Diagnosis:
    Monday, October 30, 4:04
    PM, Colorado Convention Center, Mile High Ballroom 2B-3B.
  • Advances in Structural Heart Disease Imaging (Workflow Advances,
    Automated Quantification, and Machine Learning):
    November 1, 1:15 PM, Colorado Convention Center, Room 605.

Today, physicians seek consistent, high-quality imaging studies with
quantitative assessments from imaging labs to the point of care. Such
studies aid in the timely and appropriate diagnosis and treatment of
heart disease around the world. Deep learning, a type of artificial
intelligence algorithm, has great promise to aid in the acquisition and
interpretation of echocardiographic exams (ultrasound images of the
heart) and may improve the treatment of heart diseases.

About Bay Labs

Bay Labs is a San Francisco-based privately held company focused on
increasing quality, value and access to medical imaging by combining
deep learning and ultrasound. Founded in 2013, Bay Labs applies
artificial intelligence to cardiovascular imaging, and its deep learning
technology is being designed to help medical professionals of all skill
levels perform and interpret high-quality echocardiography to ultimately
benefit their patients. Bay Labs products are for investigational use
only and currently are not for sale. For more information about Bay
Labs, visit

About Randolph P. Martin

Randolph P. Martin, FACC, FASE, FESC, MD is one of the pioneers in the
field of noninvasive cardiology, using ultrasound – echocardiography –
to diagnose cardiovascular conditions. He attended Emory University
School of Medicine, graduating summa cum laude in 1969, and went on to
hold faculty positions and clinical staff positions at Stanford
University, the University of Virginia, the Mayo Medical School and Mayo
Clinic, and Emory University, where he served as professor of medicine
and director of noninvasive cardiology for 20 years. He has over 195
publications to his credit in peer-reviewed journals and textbooks and
serves or has served on editorial boards of some of the most prestigious
cardiovascular journals. Dr. Martin is the past president of the
American Society of Echocardiography, an organization of 16,000
cardiovascular specialists and the second-largest group of
cardiovascular specialists in North America. Over his career, Dr. Martin
has been a frequent invited lecturer at national and international
cardiology conferences. Additionally, for 15 years he was medical
correspondent for WSBTV in Atlanta and was awarded the American Heart
Association's Howard L. Lewis Lifetime Achievement Award for Medical
Reporting. He currently is the chief medical officer of Bay Labs and an
emeritus professor of medicine (cardiology) at Emory University School
of Medicine.

View Comments and Join the Discussion!